Cutaneous leishmaniasis in a patient receiving infliximab for psoriatic arthritis: treatment with cryotherapy and intralesional meglumine antimonate

Actas Dermosifiliogr. 2014 Sep;105(7):714-6. doi: 10.1016/j.ad.2013.08.011. Epub 2013 Nov 22.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antiprotozoal Agents / administration & dosage*
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Psoriatic / drug therapy
  • Combined Modality Therapy
  • Cryotherapy*
  • Humans
  • Infliximab / adverse effects*
  • Infliximab / therapeutic use
  • Injections, Intralesional
  • Leishmaniasis, Cutaneous / chemically induced
  • Leishmaniasis, Cutaneous / therapy*
  • Male
  • Meglumine / administration & dosage*
  • Meglumine Antimoniate
  • Organometallic Compounds / administration & dosage*

Substances

  • Antiprotozoal Agents
  • Antirheumatic Agents
  • Organometallic Compounds
  • Meglumine
  • Meglumine Antimoniate
  • Infliximab